Deutsch
 
Mein Konto  

ANMELDEN & VORTEILE SICHERN

  • Preise & Rabatte einsehen
  • Geschenke sichern
  • Angebote anfragen & online annehmen
JETZT ANMELDEN Noch nicht registriert? Konto hier erstellen!
Vergleich
Ergebnisse
Alle Filter löschen

Ergebnisse filtern

Typ
Specific against
Host
Clone
  1. 1022C3(10)
  2. 10C6(2)
  3. 10G10(2)
  4. 1121B(10)
  5. 11B11(4)
  6. 12B5(2)
  7. 148C09(10)
  8. 164#(10)
  9. 16D7(10)
  10. 16E7#(10)
  11. 17E6#(10)
  12. 17F3(4)
  13. 18#(2)
  14. 18A5(10)
  15. 1B4(10)
  16. 1D11.16.8(2)
  17. 1H4(10)
  18. 1H7(10)
  19. 2339#(10)
  20. 23F2G(10)
  21. 25D2(2)
  22. 2B8(10)
  23. 2c3(2)
  24. 2D9(2)
  25. 3(10)
  26. 30-H12(10)
  27. 30C10(10)
  28. 30H12(2)
  29. 31#(10)
  30. 320-587(10)
  31. 356A11(2)
  32. 368D04(2)
  33. 3B3(2)
  34. 3B6(10)
  35. 3C10(2)
  36. 3H9(10)
  37. 4A4(2)
  38. 5C8(10)
  39. 5E5#(10)
  40. 5F9-G4(10)
  41. 6(10)
  42. 60(10)
  43. 6A7(2)
  44. 6D6(2)
  45. 7(10)
  46. 70(2)
  47. 7A9(10)
  48. 7C6(4)
  49. 81C6(10)
  50. 8A4(2)
  51. 8D4-8(2)
  52. 8D5(10)
  53. 9H4(10)
  54. A12(10)
  55. A14(10)
  56. A2(10)
  57. A4(10)
  58. ab324(10)
  59. ABI793(2)
  60. Abituzumab(3)
  61. ABM109(2)
  62. Abrezekimab(2)
  63. Abrilumab(3)
  64. Adalimumab Beta(3)
  65. ADCT-301(10)
  66. ADCT-602(2)
  67. ADG 153(2)
  68. Afasevikumab(3)
  69. Afelimomab(2)
  70. Aflibercept(2)
  71. Alacizumab(2)
  72. ALX148(2)
  73. AMG 811(3)
  74. Anrukinzumab(3)
  75. AO-176(2)
  76. ARGX-112(3)
  77. Aselizumab(3)
  78. Asunercept(2)
  79. AT-1501(2)
  80. AT001(3)
  81. Atacicept(2)
  82. ATG 031(2)
  83. Atrosimab(3)
  84. Avizakimab(3)
  85. B122(2)
  86. B6H12(10)
  87. BAK209B11(2)
  88. Baminercept Alfa(2)
  89. Basiliximab(3)
  90. BAT6004(2)
  91. BD0801(2)
  92. Bectumomab(2)
  93. Belimumab(3)
  94. Benralizumab(3)
  95. Benufutamab(3)
  96. Bermekimab(3)
  97. Bersanlimab(3)
  98. Bevacizumab(3)
  99. Bexmarilimab(3)
  100. Bifikafusp Alfa(2)
  101. Bimekizumab(3)
  102. BION 1301(2)
  103. Bivatuzumab(3)
  104. BlySmAb-1.1(10)
  105. Brazikumab(3)
  106. Briakinumab(3)
  107. Briobacept(2)
  108. Brolucizumab(2)
  109. BT-063(3)
  110. Burfiralimab(2)
  111. C17.8(2)
  112. C2_2E12(2)
  113. Camidanlumab(3)
  114. Camoteskimab(3)
  115. Canakinumab(3)
  116. Cantuzumab(2)
  117. CAT-02-106(2)
  118. CAT-2200(3)
  119. CC-90002(3)
  120. CDP484(3)
  121. CDP571(2)
  122. CDX-0125-TEI(2)
  123. Cendakimab(3)
  124. Certolizumab(2)
  125. Clazakizumab(3)
  126. Clivatuzumab(3)
  127. CMAB008(3)
  128. CMB-401(2)
  129. CNTO 607(3)
  130. Conatumumab(3)
  131. Conbercept(2)
  132. CYT-91000(2)
  133. D1(10)
  134. D2(4)
  135. D8P1C1(2)
  136. Daclizumab(3)
  137. Dapirolizumab(2)
  138. DC101(12)
  139. Dectrekumab(3)
  140. Denosumab(3)
  141. Depemokimab(3)
  142. Dilpacimab(2)
  143. DISC0280(3)
  144. DLX521(2)
  145. Dovanvetmab(2)
  146. Dreg-55(10)
  147. Drozitumab(3)
  148. DS-8273a(3)
  149. Dupilumab(3)
  150. Dusigitumab(3)
  151. Duvakitug(3)
  152. E4#(20)
  153. Ebdarokimab(3)
  154. Efalizumab(3)
  155. Efdamrofusp Alfa(2)
  156. Eflimrufusp Alfa(2)
  157. Eftozanermin Alfa(2)
  158. Elsilimomab(2)
  159. Emapalumab(3)
  160. ENA2(10)
  161. Enavatuzumab(3)
  162. Enlimomab(3)
  163. Enokizumab(3)
  164. Epitumomab cituxetan(2)
  165. Epratuzumab(5)
  166. Eptinezumab(3)
  167. Erlizumab(3)
  168. ESBA 105(3)
  169. Etanercept(2)
  170. Etokimab(3)
  171. Etrolizumab(3)
  172. F16(10)
  173. Faricimab(2)
  174. FD441.8(10)
  175. Fezakinumab(3)
  176. Fletikumab(3)
  177. Fontolizumab(3)
  178. Fremanezumab(3)
  179. Fresolimumab(3)
  180. Frexalimab(3)
  181. G28-8(10)
  182. G544(10)
  183. G6(2)
  184. GAL-F2(2)
  185. Galcanezumab(3)
  186. Gatipotuzumab(3)
  187. Gevokizumab(3)
  188. Golimumab(3)
  189. GSK679586(3)
  190. Gumokimab(3)
  191. Guselkumab(3)
  192. H2L6(3)
  193. H398(10)
  194. H4H10(2)
  195. H5(10)
  196. H52(2)
  197. H6(20)
  198. HB 9579(10)
  199. HFE7A(10)
  200. HM1.24(10)
  201. hMAK195(3)
  202. HMBD-004A(2)
  203. HMBD-004B(2)
  204. HMFG1(10)
  205. HMPL-a83(2)
  206. hRFB4(2)
  207. HuGAL-F2(3)
  208. hum12G8(2)
  209. HuMax-IL15(3)
  210. huS6F1(2)
  211. HW1(10)
  212. IMA-026(3)
  213. IMC-002(2)
  214. IMC-1C11(2)
  215. ImClone 6.64(3)
  216. IMM01(2)
  217. Immurait-Ll2Mab(3)
  218. Inbakicept(2)
  219. Infliximab(3)
  220. Inolimomab(3)
  221. Inotuzumab(3)
  222. Itepekimab(3)
  223. Iv0058(4)
  224. Ivonescimab(2)
  225. Ixekizumab(3)
  226. JCAR018(2)
  227. JES6-1A12(4)
  228. KHK2866(3)
  229. L117/1(2)
  230. L120/12(2)
  231. L120/30(2)
  232. L19-TNF(3)
  233. Latikafusp(2)
  234. LDP-01(2)
  235. Lebrikizumab(3)
  236. Lemzoparlimab(3)
  237. Lenercept(2)
  238. Letaplimab(3)
  239. Letolizumab(2)
  240. Lexatumumab(3)
  241. Licaminlimab(2)
  242. Ligufalimab(3)
  243. Livmoniplimab(2)
  244. LL2(10)
  245. Lutikizumab(2)
  246. LY2525623(3)
  247. LY3016859(2)
  248. M1295(3)
  249. M17/4(12)
  250. M3A1(2)
  251. M3B8(2)
  252. M971(3)
  253. M972(3)
  254. Mab1(10)
  255. Magrolimab(3)
  256. Manfidokimab(3)
  257. Mapatumumab(3)
  258. MEDI 5117(3)
  259. MEDI2045(3)
  260. MEDI3185(2)
  261. MEDI3622(2)
  262. Mepolizumab(3)
  263. Metelimumab(3)
  264. MIAP410(2)
  265. Mirikizumab(3)
  266. MO82(2)
  267. MOR101(2)
  268. MOR102(2)
  269. Moxetumomab(2)
  270. MP5-20F3(2)
  271. MR-1(2)
  272. MR1/MR-1(10)
  273. N178A/9(2)
  274. N212/17(2)
  275. N212/7(2)
  276. N275/14(2)
  277. N295B/66(2)
  278. N324/2(2)
  279. N384/63(2)
  280. N39B/8(2)
  281. N4/15(2)
  282. N4/49(2)
  283. N83/48(2)
  284. Nacolomab(2)
  285. Natalizumab(3)
  286. Navicixizumab(2)
  287. Neihulizumab(3)
  288. Nerelimomab(3)
  289. Netakimab(3)
  290. NI-1701(2)
  291. NIS793(3)
  292. NOK1/NOK-1(10)
  293. NOK2/NOK-2(10)
  294. Odulimomab(3)
  295. Olamkicept(2)
  296. Olinvacimab(3)
  297. Olokizumab(3)
  298. Ontamalimab(3)
  299. Ontorpacept(2)
  300. Opinercept(2)
  301. OV52.24(10)
  302. Ozoralizumab(2)
  303. P4D2(10)
  304. Pankomab(3)
  305. Parsatuzumab(3)
  306. Pascolizumab(3)
  307. Pateclizumab(3)
  308. PC-61.5.3(2)
  309. PC61/PC61.5.3(10)
  310. Pemtumomab(2)
  311. Perakizumab(3)
  312. PF-03475952(2)
  313. Pinatuzumab(3)
  314. Placulumab(2)
  315. Pritumumab(3)
  316. PS/2(2)
  317. PTX25(10)
  318. Pulocimab(2)
  319. R310(2)
  320. R4-6A2(2)
  321. R6N(10)
  322. RA8(2)
  323. Rademikibart(3)
  324. Radretumab(2)
  325. Ramucirumab(3)
  326. Ranibizumab(2)
  327. REGN1909(2)
  328. Remtolumab(2)
  329. Reslizumab(3)
  330. RFB-4(10)
  331. RG7356(2)
  332. Rilonacept(2)
  333. Risankizumab(3)
  334. RO5458640(3)
  335. RO7296682(2)
  336. Romilkimab(2)
  337. Rovelizumab(2)
  338. Rozipafusp alfa(2)
  339. RTX-003(2)
  340. RTX-CD47(2)
  341. Ruplizumab(3)
  342. S4B6(2)
  343. S4B6-1(2)
  344. SAA0004(20)
  345. SAA0008(10)
  346. SAA0019(10)
  347. SAA0020(10)
  348. SAA0025(10)
  349. SAA0026(10)
  350. SAA0040(10)
  351. SAA0046(10)
  352. SAA0047(10)
  353. SAA0065(10)
  354. SAA0067(10)
  355. SAA0068(10)
  356. SAA0075(10)
  357. SAA0079(10)
  358. SAA0080(10)
  359. SAA0081(10)
  360. SAA0083(10)
  361. SAA0084(10)
  362. SAA0085(10)
  363. SAA0112(10)
  364. SAA0147(10)
  365. SAA0173(10)
  366. SAA0196(2)
  367. SAA0239(2)
  368. SAA0266(2)
  369. SAA0281(2)
  370. SAA0309(2)
  371. SAA0312(10)
  372. SAA0366(10)
  373. SAA0367(10)
  374. SAA0368(10)
  375. SAA0369(10)
  376. SAA0370(10)
  377. SAA0371(10)
  378. SAA0372(10)
  379. SAA0373(10)
  380. SAA0374(10)
  381. SAA0375(10)
  382. SAA0377(10)
  383. SAA0378(10)
  384. SAA0381(10)
  385. SAA0382(10)
  386. SAA0383(10)
  387. SAA0384(10)
  388. SAA0386(10)
  389. SAA0387(10)
  390. SAA0389(10)
  391. SAA0390(10)
  392. SAA0391(10)
  393. SAA0392(10)
  394. SAA0393(10)
  395. SAA0394(10)
  396. SAA0395(10)
  397. SAA0414(10)
  398. SAA0415(10)
  399. SAA0416(10)
  400. SAA0421(10)
  401. SAA0423(10)
  402. SAA0432(10)
  403. SAA0436(10)
  404. SAA0437(10)
  405. SAA0440(10)
  406. SAA0442(10)
  407. SAA0443(10)
  408. SAA0446(10)
  409. SAA0447(10)
  410. SAA0453(10)
  411. SAA0483(10)
  412. SAA0511(10)
  413. SAA0513(10)
  414. SAA0549(10)
  415. SAA0763(10)
  416. SAA0768(2)
  417. SAA0806(10)
  418. SAA0815(10)
  419. SAA1383(10)
  420. SAA1403(10)
  421. SAA1413(10)
  422. SAA1487(10)
  423. SAA1992(10)
  424. SAA2157(10)
  425. SAA2180(10)
  426. SAA2212(10)
  427. SAA2216(10)
  428. SAA2219(10)
  429. SAR-566658(2)
  430. SAR113244(3)
  431. SAR428926(3)
  432. sB24M(2)
  433. Secukinumab(3)
  434. SG404(2)
  435. SGN CD47M(2)
  436. Sibeprenlimab(3)
  437. Siltuximab(3)
  438. Simridarlimab(2)
  439. Sirukumab(3)
  440. SM06(2)
  441. SM3(2)
  442. Sontuzumab(3)
  443. SRF231(2)
  444. SRK-181(3)
  445. SSS-23(10)
  446. ST2146(10)
  447. Stapokibart(3)
  448. STI-003(2)
  449. STI-6643(2)
  450. Suciraslimab(2)
  451. SWA11(10)
  452. T24/31(10)
  453. TAB004(2)
  454. Tabalumab(3)
  455. Tanibirumab(2)
  456. Tarcocimab(2)
  457. TAS266(4)
  458. TAY018(2)
  459. Temtokibart(3)
  460. Tenatumomab(2)
  461. TI-061(2)
  462. Tibulizumab(2)
  463. Tigatuzumab(3)
  464. Tildrakizumab(3)
  465. Tilogotamab(3)
  466. TJ-C4GM(2)
  467. Toralizumab(2)
  468. Torudokimab(3)
  469. Tozorakimab(3)
  470. TQB 2928(2)
  471. Tralokinumab(3)
  472. TTI-621(2)
  473. TTI-622(2)
  474. Tulisokibart(3)
  475. Ulocuplumab(3)
  476. Urabrelimab(3)
  477. Ustekinumab(3)
  478. VAK-694(2)
  479. Vanucizumab(2)
  480. Varisacumab(3)
  481. VB6(10)
  482. VB6-008(2)
  483. Vedolizumab(3)
  484. VFF-18(10)
  485. VGX100(3)
  486. VIS-649(10)
  487. Vopikitug(3)
  488. Vulinacimab(3)
  489. Vunakizumab(3)
  490. Vx-1004(2)
  491. Xeligekimab(2)
  492. Xentuzumab(3)
  493. XmAb 5592(3)
  494. XMG1.2(4)
  495. XOMA 089(2)
  496. XT3.11(2)
  497. YT33(2)
  498. Ziltivekimab(3)
  499. ZL-1201(2)
Applications
Isotype

Cell Biology

5419 Artikel

pro Seite

Seite:
  1. 37
  2. 38
  3. 39
  4. 40
  5. 41
Name PDF Typ Clone Specific against Appl. Host ArtNr. Menge ✓ Preis
Research Grade Bifikafusp Alfa Biosimilars Bifikafusp Alfa Hu ANSY-DHC00805-100ug

AntibodySystem 		100 ug Anmelden
Vergleichen
Research Grade Eflimrufusp Alfa Biosimilars Eflimrufusp Alfa Hu Human ANSY-DHC38202-100ug

AntibodySystem 		100 ug Anmelden
Vergleichen
Research Grade Bimekizumab Biosimilars Bimekizumab Hu ANSY-DHH28803-100ug

AntibodySystem 		100 ug Anmelden
Vergleichen
Research Grade Vunakizumab Biosimilars Vunakizumab Hu ANSY-DHH28804-100ug

AntibodySystem 		100 ug Anmelden
Vergleichen
Research Grade Netakimab Biosimilars Netakimab Hu ANSY-DHH28805-100ug

AntibodySystem 		100 ug Anmelden
Vergleichen
Research Grade Perakizumab Biosimilars Perakizumab Hu ANSY-DHH28806-100ug

AntibodySystem 		100 ug Anmelden
Vergleichen
Research Grade Afasevikumab Biosimilars Afasevikumab Hu Human ANSY-DHH28807-100ug

AntibodySystem 		100 ug Anmelden
Vergleichen
Research Grade Remtolumab Biosimilars Remtolumab Hu Human ANSY-DHH28809-100ug

AntibodySystem 		100 ug Anmelden
Vergleichen
Research Grade Tibulizumab Biosimilars Tibulizumab Hu ANSY-DHH28810-100ug

AntibodySystem 		100 ug Anmelden
Vergleichen
Research Grade Urabrelimab Biosimilars Urabrelimab Hu Human ANSY-DHG17602-100ug

AntibodySystem 		100 ug Anmelden
Vergleichen
Research Grade Ulocuplumab Biosimilars Ulocuplumab Hu Human ANSY-DHF39901-100ug

AntibodySystem 		100 ug Anmelden
Vergleichen
Research Grade Ontamalimab Biosimilars Ontamalimab Hu Human ANSY-DHG54901-100ug

AntibodySystem 		100 ug Anmelden
Vergleichen
Research Grade Secukinumab Biosimilars Secukinumab Hu Human ANSY-DHH28802-100ug

AntibodySystem 		100 ug Anmelden
Vergleichen
Research Grade Ixekizumab Biosimilars Ixekizumab Hu ANSY-DHH28801-100ug

AntibodySystem 		100 ug Anmelden
Vergleichen
Research Grade Benralizumab Biosimilars Benralizumab Hu ANSY-DHF86301-100ug

AntibodySystem 		100 ug Anmelden
Vergleichen
Research Grade Lemzoparlimab Biosimilars Lemzoparlimab Hu ANSY-DHG17603-100ug

AntibodySystem 		100 ug Anmelden
Vergleichen
Research Grade Letaplimab Biosimilars Letaplimab Hu Human ANSY-DHG17604-100ug

AntibodySystem 		100 ug Anmelden
Vergleichen
Research Grade Anti-­Human CD184/­CXCR4 Antibody (MEDI3185) Antibody Monoclonal MEDI3185 Hu Human ANSY-DHF39902-100ug

AntibodySystem 		100 ug Anmelden
Vergleichen
Research Grade Simridarlimab Biosimilars Simridarlimab Hu ANSY-DHG17605-100ug

AntibodySystem 		100 ug Anmelden
Vergleichen
Research Grade Xeligekimab Biosimilars Xeligekimab Hu ANSY-DHH28811-100ug

AntibodySystem 		100 ug Anmelden
Vergleichen
Research Grade Gumokimab Biosimilars Gumokimab Hu ANSY-DHH28812-100ug

AntibodySystem 		100 ug Anmelden
Vergleichen
Research Grade Ligufalimab Biosimilars Ligufalimab Hu ANSY-DHG17606-100ug

AntibodySystem 		100 ug Anmelden
Vergleichen
Research Grade Camoteskimab Biosimilars Camoteskimab Hu Human ANSY-DHG70701-100ug

AntibodySystem 		100 ug Anmelden
Vergleichen
Research Grade Anti-­Human CD47/­MER6 Antibody (CC-­90002) Antibody Monoclonal CC-90002 Hu ANSY-DHG17607-100ug

AntibodySystem 		100 ug Anmelden
Vergleichen
Research Grade Anti-­Human CD156b/­ADAM17 (MEDI3622) Antibody Monoclonal MEDI3622 Hu Human ANSY-DHF68801-100ug

AntibodySystem 		100 ug Anmelden
Vergleichen
Name Preis
Research Grade Bifikafusp Alfa Anmelden Research Grade Bifikafusp Alfa
Typ Biosimilars
Clone Bifikafusp Alfa
Specific against Hu
Appl.
Host
ArtNr.
Menge 100 ug
Lieferbar
Research Grade Eflimrufusp Alfa Anmelden Research Grade Eflimrufusp Alfa
Typ Biosimilars
Clone Eflimrufusp Alfa
Specific against Hu
Appl.
Host Human
ArtNr.
Menge 100 ug
Lieferbar
Research Grade Bimekizumab Anmelden Research Grade Bimekizumab
Typ Biosimilars
Clone Bimekizumab
Specific against Hu
Appl.
Host
ArtNr.
Menge 100 ug
Lieferbar
Research Grade Vunakizumab Anmelden Research Grade Vunakizumab
Typ Biosimilars
Clone Vunakizumab
Specific against Hu
Appl.
Host
ArtNr.
Menge 100 ug
Lieferbar
Research Grade Netakimab Anmelden Research Grade Netakimab
Typ Biosimilars
Clone Netakimab
Specific against Hu
Appl.
Host
ArtNr.
Menge 100 ug
Lieferbar
Research Grade Perakizumab Anmelden Research Grade Perakizumab
Typ Biosimilars
Clone Perakizumab
Specific against Hu
Appl.
Host
ArtNr.
Menge 100 ug
Lieferbar
Research Grade Afasevikumab Anmelden Research Grade Afasevikumab
Typ Biosimilars
Clone Afasevikumab
Specific against Hu
Appl.
Host Human
ArtNr.
Menge 100 ug
Lieferbar
Research Grade Remtolumab Anmelden Research Grade Remtolumab
Typ Biosimilars
Clone Remtolumab
Specific against Hu
Appl.
Host Human
ArtNr.
Menge 100 ug
Lieferbar
Research Grade Tibulizumab Anmelden Research Grade Tibulizumab
Typ Biosimilars
Clone Tibulizumab
Specific against Hu
Appl.
Host
ArtNr.
Menge 100 ug
Lieferbar
Research Grade Urabrelimab Anmelden Research Grade Urabrelimab
Typ Biosimilars
Clone Urabrelimab
Specific against Hu
Appl.
Host Human
ArtNr.
Menge 100 ug
Lieferbar
Research Grade Ulocuplumab Anmelden Research Grade Ulocuplumab
Typ Biosimilars
Clone Ulocuplumab
Specific against Hu
Appl.
Host Human
ArtNr.
Menge 100 ug
Lieferbar
Research Grade Ontamalimab Anmelden Research Grade Ontamalimab
Typ Biosimilars
Clone Ontamalimab
Specific against Hu
Appl.
Host Human
ArtNr.
Menge 100 ug
Lieferbar
Research Grade Secukinumab Anmelden Research Grade Secukinumab
Typ Biosimilars
Clone Secukinumab
Specific against Hu
Appl.
Host Human
ArtNr.
Menge 100 ug
Lieferbar
Research Grade Ixekizumab Anmelden Research Grade Ixekizumab
Typ Biosimilars
Clone Ixekizumab
Specific against Hu
Appl.
Host
ArtNr.
Menge 100 ug
Lieferbar
Research Grade Benralizumab Anmelden Research Grade Benralizumab
Typ Biosimilars
Clone Benralizumab
Specific against Hu
Appl.
Host
ArtNr.
Menge 100 ug
Lieferbar
Research Grade Lemzoparlimab Anmelden Research Grade Lemzoparlimab
Typ Biosimilars
Clone Lemzoparlimab
Specific against Hu
Appl.
Host
ArtNr.
Menge 100 ug
Lieferbar
Research Grade Letaplimab Anmelden Research Grade Letaplimab
Typ Biosimilars
Clone Letaplimab
Specific against Hu
Appl.
Host Human
ArtNr.
Menge 100 ug
Lieferbar
Research Grade Anti-­Human CD184/­CXCR4 Antibody (MEDI3185) Anmelden Research Grade Anti-Human CD184/CXCR4 Antibody (MEDI3185)
Typ Antibody Monoclonal
Clone MEDI3185
Specific against Hu
Appl.
Host Human
ArtNr.
Menge 100 ug
Lieferbar
Research Grade Simridarlimab Anmelden Research Grade Simridarlimab
Typ Biosimilars
Clone Simridarlimab
Specific against Hu
Appl.
Host
ArtNr.
Menge 100 ug
Lieferbar
Research Grade Xeligekimab Anmelden Research Grade Xeligekimab
Typ Biosimilars
Clone Xeligekimab
Specific against Hu
Appl.
Host
ArtNr.
Menge 100 ug
Lieferbar
Research Grade Gumokimab Anmelden Research Grade Gumokimab
Typ Biosimilars
Clone Gumokimab
Specific against Hu
Appl.
Host
ArtNr.
Menge 100 ug
Lieferbar
Research Grade Ligufalimab Anmelden Research Grade Ligufalimab
Typ Biosimilars
Clone Ligufalimab
Specific against Hu
Appl.
Host
ArtNr.
Menge 100 ug
Lieferbar
Research Grade Camoteskimab Anmelden Research Grade Camoteskimab
Typ Biosimilars
Clone Camoteskimab
Specific against Hu
Appl.
Host Human
ArtNr.
Menge 100 ug
Lieferbar
Research Grade Anti-­Human CD47/­MER6 Antibody (CC-­90002) Anmelden Research Grade Anti-Human CD47/MER6 Antibody (CC-90002)
Typ Antibody Monoclonal
Clone CC-90002
Specific against Hu
Appl.
Host
ArtNr.
Menge 100 ug
Lieferbar
Research Grade Anti-­Human CD156b/­ADAM17 (MEDI3622) Anmelden Research Grade Anti-Human CD156b/ADAM17 (MEDI3622)
Typ Antibody Monoclonal
Clone MEDI3622
Specific against Hu
Appl.
Host Human
ArtNr.
Menge 100 ug
Lieferbar

5419 Artikel

pro Seite

Seite:
  1. 37
  2. 38
  3. 39
  4. 40
  5. 41
Kontakt

Hölzel Diagnostika Handels GmbH
Weinsbergstr 118a
D-50823 Köln

T +49 221 126 02 66
F +49 221 126 02 67

info@hoelzel.de

Über Hölzel
Service
Infothek
Spendenaktion Datenschutzsiegel

Copyright 2025 Hölzel Diagnostika Handels GmbH

To top